We investigated DM1 brain abnormalities with TBSS, VBM and cortical thickness analysis.
White matter lesion refilling has been performed to improve voxel-wise analyses.
All patients have been evaluated using a clinical scale created ad hoc for DM1.
DM1 patients present diffuse white and cortical-subcortical gray matter disruption.
White matter differences are correlated with clinical and genetic features.